Rubin J et al. |
IGF-I regulates osteoprotegerin (OPG) and receptor activator of nuclear factor-kappaB ligand in vitro and OPG in vivo. |
2002 |
J. Clin. Endocrinol. Metab. |
pmid:12213884
|
Palmqvist P et al. |
IL-6, leukemia inhibitory factor, and oncostatin M stimulate bone resorption and regulate the expression of receptor activator of NF-kappa B ligand, osteoprotegerin, and receptor activator of NF-kappa B in mouse calvariae. |
2002 |
J. Immunol. |
pmid:12218157
|
Sandor M et al. |
A novel polyethylene depot device for the study of PLGA and P(FASA) microspheres in vitro and in vivo. |
2002 |
Biomaterials |
pmid:12219832
|
Shiotani A et al. |
Regulation of osteoclast differentiation and function by receptor activator of NFkB ligand and osteoprotegerin. |
2002 |
Anat. Rec. |
pmid:12221720
|
Kudo O et al. |
Proinflammatory cytokine (TNFalpha/IL-1alpha) induction of human osteoclast formation. |
2002 |
J. Pathol. |
pmid:12237882
|
Hofbauer LC et al. |
High bone density due to a mutation in LDL-receptor-related protein 5. |
2002 |
N. Engl. J. Med. |
pmid:12240686
|
Williamson E et al. |
Regulation of mucosal dendritic cell function by receptor activator of NF-kappa B (RANK)/RANK ligand interactions: impact on tolerance induction. |
2002 |
J. Immunol. |
pmid:12244151
|
Ferrer Cañabate J et al. |
[Osteoprotegrin and RANKL/RANK system: is it the future of bone metabolism?]. |
2002 |
An Med Interna |
pmid:12244784
|
Kazama JJ et al. |
Circulating osteoprotegerin is not removed through haemodialysis membrane. |
2002 |
Nephrol. Dial. Transplant. |
pmid:12271009
|
Lee SW et al. |
TAK1-dependent activation of AP-1 and c-Jun N-terminal kinase by receptor activator of NF-kappaB. |
2002 |
J. Biochem. Mol. Biol. |
pmid:12296995
|
Standal T et al. |
Osteoprotegerin is bound, internalized, and degraded by multiple myeloma cells. |
2002 |
Blood |
pmid:12351414
|
|
|
|
|
pmid:12354528
|
Yang SY et al. |
Adeno-associated virus-mediated osteoprotegerin gene transfer protects against particulate polyethylene-induced osteolysis in a murine model. |
2002 |
Arthritis Rheum. |
pmid:12355500
|
Palenzuela L et al. |
Familial expansile osteolysis in a large Spanish kindred resulting from an insertion mutation in the TNFRSF11A gene. |
2002 |
J. Med. Genet. |
pmid:12362049
|
Fu Q et al. |
Parathyroid hormone stimulates receptor activator of NFkappa B ligand and inhibits osteoprotegerin expression via protein kinase A activation of cAMP-response element-binding protein. |
2002 |
J. Biol. Chem. |
pmid:12364326
|
Rogers A et al. |
Circulating estradiol and osteoprotegerin as determinants of bone turnover and bone density in postmenopausal women. |
2002 |
J. Clin. Endocrinol. Metab. |
pmid:12364420
|
Romas E et al. |
Osteoprotegerin reduces osteoclast numbers and prevents bone erosion in collagen-induced arthritis. |
2002 |
Am. J. Pathol. |
pmid:12368214
|
Rude RK et al. |
Magnesium deficiency: effect on bone and mineral metabolism in the mouse. |
2003 |
Calcif. Tissue Int. |
pmid:12370796
|
David JP et al. |
JNK1 modulates osteoclastogenesis through both c-Jun phosphorylation-dependent and -independent mechanisms. |
2002 |
J. Cell. Sci. |
pmid:12376563
|
Jones DH et al. |
Role of RANKL and RANK in bone loss and arthritis. |
2002 |
Ann. Rheum. Dis. |
pmid:12379618
|
Gravallese EM |
Bone destruction in arthritis. |
2002 |
Ann. Rheum. Dis. |
pmid:12379632
|
Abrahamsen B et al. |
Effects of the natural and artificial menstrual cycle on the production of osteoprotegerin and the bone resorptive cytokines IL-1beta and IL-6. |
2003 |
Calcif. Tissue Int. |
pmid:12384814
|
Suda T et al. |
[Merger of bone biology and immunology]. |
2002 |
Tanpakushitsu Kakusan Koso |
pmid:12385106
|
Nagasawa T et al. |
LPS-stimulated human gingival fibroblasts inhibit the differentiation of monocytes into osteoclasts through the production of osteoprotegerin. |
2002 |
Clin. Exp. Immunol. |
pmid:12390325
|
Cremer I et al. |
Long-lived immature dendritic cells mediated by TRANCE-RANK interaction. |
2002 |
Blood |
pmid:12393586
|
Giuliani N et al. |
Human myeloma cells stimulate the receptor activator of nuclear factor-kappa B ligand (RANKL) in T lymphocytes: a potential role in multiple myeloma bone disease. |
2002 |
Blood |
pmid:12393684
|
Liao EY et al. |
Comparison of the effects of 17beta-E2 and progesterone on the expression of osteoprotegerin in normal human osteoblast-like cells. |
2002 |
J. Endocrinol. Invest. |
pmid:12398237
|
Okada Y et al. |
Cell-to-Cell adhesion via intercellular adhesion molecule-1 and leukocyte function-associated antigen-1 pathway is involved in 1alpha,25(OH)2D3, PTH and IL-1alpha-induced osteoclast differentiation and bone resorption. |
2002 |
Endocr. J. |
pmid:12402981
|
Jung K et al. |
Osteoprotegerin and receptor activator of nuclear factor-kappaB ligand (RANKL) in the serum of healthy adults. |
2002 Jul-Sep |
Int. J. Biol. Markers |
pmid:12408468
|
Yamada T et al. |
Regulation of osteoclast development by Notch signaling directed to osteoclast precursors and through stromal cells. |
2003 |
Blood |
pmid:12411305
|
Roodman GD |
Role of the bone marrow microenvironment in multiple myeloma. |
2002 |
J. Bone Miner. Res. |
pmid:12412796
|
Hegedus D et al. |
Decreased bone density, elevated serum osteoprotegerin, and beta-cross-laps in Wilson disease. |
2002 |
J. Bone Miner. Res. |
pmid:12412803
|
Zhao S et al. |
MLO-Y4 osteocyte-like cells support osteoclast formation and activation. |
2002 |
J. Bone Miner. Res. |
pmid:12412815
|
Hu Y and Yu S |
Gene expression of osteoprotegerin and osteoclast differentiation factor in giant cell tumor. |
2002 |
Zhonghua Bing Li Xue Za Zhi |
pmid:12419159
|
Sezer O et al. |
RANK ligand and osteoprotegerin in myeloma bone disease. |
2003 |
Blood |
pmid:12424190
|
Stejskal D et al. |
Osteoprotegerin, RANK, RANKL. |
2001 |
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub |
pmid:12426773
|
Stejskal D et al. |
Osteoprotegerin and bone density. |
2001 |
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub |
pmid:12426776
|
Lubberts E et al. |
Increase in expression of receptor activator of nuclear factor kappaB at sites of bone erosion correlates with progression of inflammation in evolving collagen-induced arthritis. |
2002 |
Arthritis Rheum. |
pmid:12428250
|
Crotti TN et al. |
Receptor activator NF-kappaB ligand (RANKL) expression in synovial tissue from patients with rheumatoid arthritis, spondyloarthropathy, osteoarthritis, and from normal patients: semiquantitative and quantitative analysis. |
2002 |
Ann. Rheum. Dis. |
pmid:12429533
|
Hofbauer LC and Schoppet M |
Osteoprotegerin deficiency and juvenile Paget's disease. |
2002 |
N. Engl. J. Med. |
pmid:12432053
|
Liegibel UM et al. |
Concerted action of androgens and mechanical strain shifts bone metabolism from high turnover into an osteoanabolic mode. |
2002 |
J. Exp. Med. |
pmid:12438430
|
Bolon B et al. |
Duration of bone protection by a single osteoprotegerin injection in rats with adjuvant-induced arthritis. |
2002 |
Cell. Mol. Life Sci. |
pmid:12440777
|
Yamashita T et al. |
Double mutations in klotho and osteoprotegerin gene loci rescued osteopetrotic phenotype. |
2002 |
Endocrinology |
pmid:12446599
|
Shimizu-Ishiura M et al. |
Osteoprotegerin administration reduces femural bone loss in ovariectomized mice via impairment of osteoclast structure and function. |
2002 |
J Electron Microsc (Tokyo) |
pmid:12455916
|
Liu D et al. |
Expression of RANKL and OPG mRNA in periodontal disease: possible involvement in bone destruction. |
2003 |
Int. J. Mol. Med. |
pmid:12469211
|
Cho CH and Nuttall ME |
Emerging techniques for the discovery and validation of therapeutic targets for skeletal diseases. |
2002 |
Expert Opin. Ther. Targets |
pmid:12472380
|
Hasegawa T et al. |
Expression of receptor activator of NF-kappa B ligand and osteoprotegerin in culture of human periodontal ligament cells. |
2002 |
J. Periodont. Res. |
pmid:12472833
|
Avbersek-Luznik I et al. |
Increased levels of osteoprotegerin in hemodialysis patients. |
2002 |
Clin. Chem. Lab. Med. |
pmid:12476941
|
Buckley KA et al. |
Adenosine triphosphate stimulates human osteoclast activity via upregulation of osteoblast-expressed receptor activator of nuclear factor-kappa B ligand. |
2002 |
Bone |
pmid:12477572
|
McCauley LK and Nohutcu RM |
Mediators of periodontal osseous destruction and remodeling: principles and implications for diagnosis and therapy. |
2002 |
J. Periodontol. |
pmid:12479643
|
Bolon B et al. |
Osteoprotegerin, an endogenous antiosteoclast factor for protecting bone in rheumatoid arthritis. |
2002 |
Arthritis Rheum. |
pmid:12483715
|
Golmia RP et al. |
Increased osteoprotegerin and decreased pyridinoline levels in patients with ankylosing spondylitis: comment on the article by Gratacós et al. |
2002 |
Arthritis Rheum. |
pmid:12483748
|
Toraldo G et al. |
IL-7 induces bone loss in vivo by induction of receptor activator of nuclear factor kappa B ligand and tumor necrosis factor alpha from T cells. |
2003 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:12490655
|
Choi BK et al. |
Induction of osteoclastogenesis and matrix metalloproteinase expression by the lipooligosaccharide of Treponema denticola. |
2003 |
Infect. Immun. |
pmid:12496170
|
Bengtsson AK and Ryan EJ |
Immune function of the decoy receptor osteoprotegerin. |
2002 |
Crit. Rev. Immunol. |
pmid:12498383
|
Chagraoui H et al. |
Stimulation of osteoprotegerin production is responsible for osteosclerosis in mice overexpressing TPO. |
2003 |
Blood |
pmid:12506018
|
Lee Y et al. |
Differences in the cytokine profiles associated with prostate cancer cell induced osteoblastic and osteolytic lesions in bone. |
2003 |
J. Orthop. Res. |
pmid:12507581
|
Sabokbar A et al. |
Two distinct cellular mechanisms of osteoclast formation and bone resorption in periprosthetic osteolysis. |
2003 |
J. Orthop. Res. |
pmid:12507582
|
Elhasid R et al. |
Familial severe congenital neutropenia associated with infantile osteoporosis: a new entity. |
2003 |
Am. J. Hematol. |
pmid:12508266
|
Haynes DR et al. |
Osteoprotegerin expression in synovial tissue from patients with rheumatoid arthritis, spondyloarthropathies and osteoarthritis and normal controls. |
2003 |
Rheumatology (Oxford) |
pmid:12509625
|
Takayanagi H |
[Cross-talk between immune and skeletal systems]. |
2002 |
Nippon Rinsho |
pmid:12510352
|
Spyrou P et al. |
Cytokine release by osteoblast-like cells cultured on implant discs of varying alloy compositions. |
2002 |
Clin Oral Implants Res |
pmid:12519337
|
Berenson JR |
Advances in the biology and treatment of myeloma bone disease. |
2002 |
Semin. Oncol. |
pmid:12520479
|
Woo KM et al. |
Osteoprotegerin is present on the membrane of osteoclasts isolated from mouse long bones. |
2002 |
Exp. Mol. Med. |
pmid:12526098
|
Kanematsu M et al. |
[Effects of gravity on the gene expression of osteoclast differentiation factor and osteoclastogenesis inhibitory factor]. |
1999 |
Biol. Sci. Space |
pmid:12532992
|
Katavić V et al. |
Increased bone mass is a part of the generalized lymphoproliferative disorder phenotype in the mouse. |
2003 |
J. Immunol. |
pmid:12538719
|
Clohisy D |
Cellular mechanisms of osteolysis. |
2003 |
J Bone Joint Surg Am |
pmid:12540662
|
Vanderkerken K et al. |
Recombinant osteoprotegerin decreases tumor burden and increases survival in a murine model of multiple myeloma. |
2003 |
Cancer Res. |
pmid:12543775
|
Kato I et al. |
TRANCE together with IL-7 induces pre-B cells to proliferate. |
2003 |
Eur. J. Immunol. |
pmid:12548564
|
Sordillo EM and Pearse RN |
RANK-Fc: a therapeutic antagonist for RANK-L in myeloma. |
2003 |
Cancer |
pmid:12548579
|
Oyajobi BO and Mundy GR |
Receptor activator of NF-kappaB ligand, macrophage inflammatory protein-1alpha, and the proteasome: novel therapeutic targets in myeloma. |
2003 |
Cancer |
pmid:12548580
|
Croucher PI et al. |
Bisphosphonates and osteoprotegerin as inhibitors of myeloma bone disease. |
2003 |
Cancer |
pmid:12548581
|
Lipton A |
Bisphosphonates and metastatic breast carcinoma. |
2003 |
Cancer |
pmid:12548585
|
Demers LM |
Bone markers in the management of patients with skeletal metastases. |
2003 |
Cancer |
pmid:12548589
|
Body JJ et al. |
A phase I study of AMGN-0007, a recombinant osteoprotegerin construct, in patients with multiple myeloma or breast carcinoma related bone metastases. |
2003 |
Cancer |
pmid:12548591
|
Kanematsu M et al. |
[Clinostat rotation culture modulates gene expression of osteoclastogenesis-regulating factors via a cyclic-AMP dependent mechanism]. |
2000 |
Biol. Sci. Space |
pmid:12561872
|
Buckley KA and Fraser WD |
Receptor activator for nuclear factor kappaB ligand and osteoprotegerin: regulators of bone physiology and immune responses/potential therapeutic agents and biochemical markers. |
2002 |
Ann. Clin. Biochem. |
pmid:12564836
|
Xing L et al. |
Expression of either NF-kappaB p50 or p52 in osteoclast precursors is required for IL-1-induced bone resorption. |
2003 |
J. Bone Miner. Res. |
pmid:12568403
|
Cao J et al. |
Expression of RANKL and OPG correlates with age-related bone loss in male C57BL/6 mice. |
2003 |
J. Bone Miner. Res. |
pmid:12568404
|
Johnson-Pais TL et al. |
Identification of a novel tandem duplication in exon 1 of the TNFRSF11A gene in two unrelated patients with familial expansile osteolysis. |
2003 |
J. Bone Miner. Res. |
pmid:12568416
|
Clohisy JC et al. |
RANKL is an essential cytokine mediator of polymethylmethacrylate particle-induced osteoclastogenesis. |
2003 |
J. Orthop. Res. |
pmid:12568950
|
Yu Q et al. |
Cooperation of TNF family members CD40 ligand, receptor activator of NF-kappa B ligand, and TNF-alpha in the activation of dendritic cells and the expansion of viral specific CD8+ T cell memory responses in HIV-1-infected and HIV-1-uninfected individuals. |
2003 |
J. Immunol. |
pmid:12574344
|
Rifas L et al. |
Inflammatory T cells rapidly induce differentiation of human bone marrow stromal cells into mature osteoblasts. |
2003 |
J. Cell. Biochem. |
pmid:12577299
|
Gordeladze JO and Reseland JE |
A unified model for the action of leptin on bone turnover. |
2003 |
J. Cell. Biochem. |
pmid:12577304
|
Fahrleitner A et al. |
Serum osteoprotegerin is a major determinant of bone density development and prevalent vertebral fracture status following cardiac transplantation. |
2003 |
Bone |
pmid:12584041
|
Lanzi R et al. |
GH replacement therapy increases plasma osteoprotegerin levels in GH-deficient adults. |
2003 |
Eur. J. Endocrinol. |
pmid:12590637
|
Lubberts E et al. |
IL-17 promotes bone erosion in murine collagen-induced arthritis through loss of the receptor activator of NF-kappa B ligand/osteoprotegerin balance. |
2003 |
J. Immunol. |
pmid:12594294
|
Stajszczyk M |
[Role of receptor activator of nuclear factor kappa B (RANK), its ligand (RANK-L) and osteoprotegerin (OPG) in bone metabolism]. |
2002 |
Pol. Arch. Med. Wewn. |
pmid:12600190
|
Fahrleitner A et al. |
Serum osteoprotegerin levels in patients after liver transplantation and correlation to bone turnover, bone mineral density and fracture status. |
2002 |
Wien. Klin. Wochenschr. |
pmid:12602117
|
Shipman CM and Croucher PI |
Osteoprotegerin is a soluble decoy receptor for tumor necrosis factor-related apoptosis-inducing ligand/Apo2 ligand and can function as a paracrine survival factor for human myeloma cells. |
2003 |
Cancer Res. |
pmid:12615702
|
Hamzei M et al. |
Osteoclast stimulating and differentiating factors in human cholesteatoma. |
2003 |
Laryngoscope |
pmid:12616193
|
Siggelkow H et al. |
Cytokines, osteoprotegerin, and RANKL in vitro and histomorphometric indices of bone turnover in patients with different bone diseases. |
2003 |
J. Bone Miner. Res. |
pmid:12619938
|
Wiethe C et al. |
Provision of 4-1BB ligand enhances effector and memory CTL responses generated by immunization with dendritic cells expressing a human tumor-associated antigen. |
2003 |
J. Immunol. |
pmid:12626542
|
Ueland T et al. |
Age-related changes in cortical bone content of insulin-like growth factor binding protein (IGFBP)-3, IGFBP-5, osteoprotegerin, and calcium in postmenopausal osteoporosis: a cross-sectional study. |
2003 |
J. Clin. Endocrinol. Metab. |
pmid:12629078
|
Schoppet M et al. |
Increased osteoprotegerin serum levels in men with coronary artery disease. |
2003 |
J. Clin. Endocrinol. Metab. |
pmid:12629080
|
Han W et al. |
Construction of a new tumour necrosis factor fusion-protein expression vector for high-level expression of heterologous genes in Escherichia coli. |
2003 |
Biotechnol. Appl. Biochem. |
pmid:12630898
|
Koshihara Y et al. |
Vitamin K stimulates osteoblastogenesis and inhibits osteoclastogenesis in human bone marrow cell culture. |
2003 |
J. Endocrinol. |
pmid:12630919
|
Alvarez L et al. |
Serum osteoprotegerin and its ligand in Paget's disease of bone: relationship to disease activity and effect of treatment with bisphosphonates. |
2003 |
Arthritis Rheum. |
pmid:12632438
|
Bord S et al. |
The effects of estrogen on osteoprotegerin, RANKL, and estrogen receptor expression in human osteoblasts. |
2003 |
Bone |
pmid:12633785
|
Smith MD et al. |
Microarchitecture and protective mechanisms in synovial tissue from clinically and arthroscopically normal knee joints. |
2003 |
Ann. Rheum. Dis. |
pmid:12634226
|